Don’t invest unless you’re prepared to lose all the money you invest. This is a high‑risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

Octiocor at KQ

Octiocor talks AI at KQ Labs

Portfolio company Octiocor recently took part in a KQ Labs demo day.

Our portfolio company, Octiocor, participated in yesterday’s KQ Labs Cohort 6 Demo Day’, which featured presentations from ten companies developing breakthrough solutions in the healthtech space.

The Octiocor team talked about their AI-driven software that interprets intravascular coronary artery images for clinical trials analysis and real-time decision support for cardiologists for better decisions to prevent future heart attacks in high-risk patients.

Octiocor’s software will provide real-time crucial decision support during high-risk stenting procedures. Additionally, it will enhance clinical end-points with risk prediction in clinical trials, improving the effectiveness of new drugs and stents and ultimately advancing atherosclerosis treatment outcomes.

Find more information about Octiocor on their website: